These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1422615)

  • 1. Factors associated with relapse among opiate addicts in an out-patient detoxification programme.
    Unnithan S; Gossop M; Strang J
    Br J Psychiatry; 1992 Nov; 161():654-7. PubMed ID: 1422615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumstances surrounding the initial lapse to opiate use following detoxification.
    Bradley BP; Phillips G; Green L; Gossop M
    Br J Psychiatry; 1989 Mar; 154():354-9. PubMed ID: 2597837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can opiate addicts tell us about their relapse risk? Subjective predictors of clinical prognosis.
    Powell J; Dawe S; Richards D; Gossop M; Marks I; Strang J; Gray J
    Addict Behav; 1993; 18(4):473-90. PubMed ID: 8213302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-detoxification by opiate addicts. A preliminary investigation.
    Gossop M; Battersby M; Strang J
    Br J Psychiatry; 1991 Aug; 159():208-12. PubMed ID: 1663410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of opiate drug abuse during a 90-day methadone detoxification.
    Iguchi MY; Stitzer ML
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):279-94. PubMed ID: 1928022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification].
    Jovanović T; Lazarević D; Nikolić G
    Vojnosanit Pregl; 2012 Apr; 69(4):326-32. PubMed ID: 22624424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of drugs and psychological proneness in opioid addiction.
    Barrett ME; Joe GW; Simpson DD
    Int J Addict; 1990 Oct; 25(10):1211-26. PubMed ID: 2090624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes.
    Gossop M; Griffiths P; Bradley B; Strang J
    Br J Psychiatry; 1989 Mar; 154():360-3. PubMed ID: 2688778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study.
    Gossop M; Green L; Phillips G; Bradley B
    Br J Psychiatry; 1989 Mar; 154():348-53. PubMed ID: 2597836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should opiate addicts be involved in controlling their own detoxification? A comparison of fixed versus negotiable schedules.
    Dawe S; Griffiths P; Gossop M; Strang J
    Br J Addict; 1991 Aug; 86(8):977-82. PubMed ID: 1912752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with noncompliance with methadone substitution therapy (MST) and relapse among chronic opiate users in an Outer London community.
    Mutasa HC
    J Adv Nurs; 2001 Jul; 35(1):97-107. PubMed ID: 11442687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of out-patient opiate addicts to the provision of a temporary increase in their prescribed drugs.
    Gossop M; Strang J; Connell PH
    Br J Psychiatry; 1982 Oct; 141():338-43. PubMed ID: 7171908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.
    Metrebian N; Shanahan W; Wells B; Stimson GV
    Med J Aust; 1998 Jun; 168(12):596-600. PubMed ID: 9673620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
    Scherbaum N; Heppekausen K; Rist F
    Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse in opiate addicts: a behavioral analysis.
    Chaney EF; Roszell DK; Cummings C
    Addict Behav; 1982; 7(3):291-7. PubMed ID: 7180624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Relapse among Heroin Addicts: Evidence from a Two-Year Community-Based Follow-Up Study in China.
    Rong C; Jiang HF; Zhang RW; Zhang LJ; Zhang JC; Zhang J; Feng XS
    Int J Environ Res Public Health; 2016 Jan; 13(2):177. PubMed ID: 26828510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind study of neuroelectric therapy in opiate and cocaine detoxification.
    Gariti P; Auriacombe M; Incmikoski R; McLellan AT; Patterson L; Dhopesh V; Mezochow J; Patterson M; O'Brien C
    J Subst Abuse; 1992; 4(3):299-308. PubMed ID: 1458046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.